window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : September 14, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

life sciences supply chain

  • Biotech & Pharma Business,Manufacturing & Supply Chain

    Brenntag signs Eastern Europe nutraceutical distribution deal

    Brenntag has signed an exclusive distribution agreement with Zeus Hygia [...]

    August 28, 2026
  • Manufacturing & Supply Chain

    TraceLink MINT transaction volume surges 183% in 2026

    TraceLink’s MINT platform has recorded more supply chain transaction activity [...]

    August 24, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain

    Miebach Consulting doubles Oxfordshire footprint to support life sciences supply chains at Abingdon Science Park

    Categories: Biomanufacturing, Biotech, Supply Chain & Logistics, Technology and platforms, [...]

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Biogen’s felzartamab approved in China for multiple myeloma
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Pharmaceuticals and therapeutics
  • Agenus reports deep responses with immunotherapy in Phase 2 colon cancer study
    Categories: Advanced Therapies, Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development
  • CEPI funds Minapharm’s Phase 1 Bundibugyo Ebola vaccine programme
    Categories: Advanced Therapies, Biotech & Pharma Business, Clinical & Regulatory, Manufacturing & Supply Chain, Pharmaceuticals and therapeutics, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top